PET/CT and MR imaging biomarker of lipid-rich plaques using [64Cu]-labeled scavenger receptor (CD68-Fc)

International Journal of Cardiology

Volumn 177, Issue 1, 2014, Pages 287-291

  Bigalke, Boris ^a,b   Phinikaridou, Alkystis ^a   Andia, Marcelo E ^a,c   Cooper, Margaret S ^a   Schuster, Andreas ^a,d,e   Wurster, Thomas ^f   Onthank, David ^g   Münch, Götz ^h   Blower, Philip ^a   Gawaz, Meinrad ^f   Nagel, Eike ^a,i,j   Botnar, Rene M ^a,h,i,j  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g Clinical Research   (United States)

^h ADVANCECOR GMBH   (Germany)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

more..

Author keywords

64Cu labeled CD68 Fc; ApoE mice; Atherosclerosis; Imaging biomarker of plaque erosion; PET CT and MRI

Indexed keywords

BIOLOGICAL MARKER; COPPER CD68 ANTIGEN FC RECEPTOR CU 64; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CD68 PROTEIN, MOUSE; COPPER; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; SCAVENGER RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIAC IMAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG UPTAKE; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; ANIMAL; C57BL MOUSE; COMMON CAROTID ARTERY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DISEASE MODEL; METABOLISM; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CAROTID ARTERY, COMMON; COPPER RADIOISOTOPES; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, SCAVENGER; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84909944267     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.017     Document Type: Article

References (40)

1. D. Steinberg, S. Parthasarathy, and T.E. Carew Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
2. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
3. M.P. Ramprasad, V. Terpstra, and N. Kondratenko Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein Proc Natl Acad Sci U S A 93 1996 14833 14838
4. S. Zeibig, Z. Li, and S. Wagner Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis Circ Res 108 2011 695 703
5. K. Daub, D. Siegel-Axel, and T. Schönberger Inhibition of foam cell formation using a soluble CD68-Fc fusion protein J Mol Med (Berl) 88 2010 909 920
6. H.F. Langer, R. Haubner, and B.J. Pichler Radionuclide imaging: a molecular key to the atherosclerotic plaque J Am Coll Cardiol 52 2008 1 12
7. B. Bigalke, A. Phinikaridou, and M.E. Andia Positron emission tomography/computed tomographic and magnetic resonance imaging in a murine model of progressive atherosclerosis using (64)Cu-labeled glycoprotein VI-Fc Circ Cardiovasc Imaging 6 2013 957 964
8. M. Gawaz, S. Vogel, and C. Pfannenberg Implications of glycoprotein VI for theranostics Thromb Haemost 112 2014 26 31
9. M.S. Cooper, E. Sabbah, and S.J. Mather Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes Nat Protoc 1 2006 314 317
10. M.R. Makowski, G. Varma, and A. Wiethoff Non-invasive assessment of atherosclerotic plaque progression in ApoE-/ - mice using susceptibility gradient mapping Circ Cardiovasc Imaging 4 2011 295 303
11. M.R. Makowski, A.J. Wiethoff, and U. Blume Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent Nat Med 17 2011 383 388
12. A. Phinikaridou, M.E. Andia, and A. Indermuehle Vascular remodeling and plaque vulnerability in a rabbit model of atherosclerosis: comparison of delayed-enhancement mr imaging with an elastin-specific contrast agent and unenhanced black-blood MR imaging Radiology 271 2014 390 399
13. A. Phinikaridou, M.E. Andia, and A. Protti Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent Circulation 126 2012 707 719
14. T. Schönberger, D. Siegel-Axel, and R. Bussl The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice Cardiovasc Res 80 2008 131 137
15. M. Noutsias, C. Hohmann, and M. Pauschinger sICAM-1 correlates with myocardial ICAM-1 expression in dilated cardiomyopathy Int J Cardiol 91 2003 153 161
16. I. Szanda, J. Mackewn, and G. Patay National electrical manufacturers association NU-4 performance evaluation of the PET component of the nanoPET/CT preclinical PET/CT scanner J Nucl Med 52 2011 1741 1747
17. U. Blume, J. Orbell, and M. Waltham 3d t(1)-mapping for the characterization of deep vein thrombosis MAGMA 22 2009 375 383
18. A. Schuster, M.R. Makowski, and C.H. Jansen Platelets in cardiovascular imaging Curr Vasc Pharmacol 10 2012 619 625
19. M.R. Makowski, and R.M. Botnar MR imaging of the arterial vessel wall: molecular imaging from bench to bedside Radiology 269 2013 34 51
20. M. Naghavi, P. Libby, and E. Falk From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I Circulation 108 2003 1664 1672
21. M.S. Judenhofer, H.F. Wehrl, and D.F. Newport Simultaneous PET-MRI: a new approach for functional and morphological imaging Nat Med 14 2008 459 465
22. N.V. Joshi, A.T. Vesey, and M.C. Williams 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial Lancet 383 2014 705 713
23. M.D. Majmudar, and M. Nahrendorf Cardiovascular molecular imaging: the road ahead J Nucl Med 53 2012 673 676
24. M. Nahrendorf, H. Zhang, and S. Hembrador Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis Circulation 117 2008 379 387
25. W.W. Lee, B. Marinelli, and A.M. van der Laan PET/MRI of inflammation in myocardial infarction J Am Coll Cardiol 59 2012 153 163
26. S. Allahverdian, A.C. Chehroudi, and B.M. McManus Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis Circulation 129 2014 1551 1559
27. W. Chen, D.P. Cormode, and Y. Vengrenyuk Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression JACC Cardiovasc Imaging 6 2013 373 384
28. K. Daub, P. Seizer, and K. Stellos Oxidized LDL-activated platelets induce vascular inflammation Semin Thromb Hemost 36 2010 146 156
29. K. Stellos, R. Sauter, and M. Fahrleitner Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo - brief report Arterioscler Thromb Vasc Biol 32 2012 2017 2020
30. B. Bai, A. Ruangma, and R. Laforest Positron range modeling for statistical PET image reconstruction IEEE Nucl Sci Symp Conf Rec 4 2004 2501 2505
31. Y. Liu, D. Abendschein, and G.E. Woodard Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET J Nucl Med 51 2010 85 91
32. N.J. Stone, J. Robinson, and A.H. Lichtenstein 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2013 2889 2934
33. M. Yogo, M. Sasaki, and M. Ayaori Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: serial magnetic resonance imaging observations from RAPID study Atherosclerosis 232 2014 31 39
34. M.J. Wolk, S.R. Bailey, and J.U. Doherty ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons J Am Coll Cardiol 63 2014 380 406
35. D.C. Burgess, D. Hunt, and L. Li Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study Eur Heart J 31 2010 92 99
36. R.Y. Kwong, H. Sattar, and H. Wu Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction Circulation 118 2008 1011 1020
37. A.I.M.-H.I.G.H. Investigators, W.E. Boden, and J.L. Probstfield Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
38. Cholesterol Treatment Trialists' (CTT) Collaborators B. Mihaylova, and J. Emberson The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials Lancet 380 2012 581 590
39. M.J. Pencina, A.M. Navar-Boggan, and R.B. D'Agostino Sr. Application of new cholesterol guidelines to a population-based sample N Engl J Med 370 2014 1422 1431
40. L.G. Shewan, G.M.C. Rosano, and M.Y. Henein Ethics in the authorship and publishing of scientific articles Int J Cardiol 170 2014 253 254